Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People”

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is one of the stocks Jim Cramer shared insights on. Inquiring about the stock during the lightning round, a caller expressed that their son and grandson use products made by the company. Here’s what Cramer had to say in response:

“Alright, so… this is one of those, this is really difficult because I want to go with them, and the reason I want to go with them is they’re young. If they made a mistake, they got their whole life ahead of them. They’ve had the personal use of it. I looked at the company and said, jeez, I don’t like the fact that they keep losing money, but you know what? Let’s go with them and see what happens. Speculative stock for younger people, I actually encourage.”

Stock market data on a laptop screen. Photo by Alesia Kozik on Pexels

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) develops insulin delivery systems and digital health tools, infusion sets, cartridges, and platforms to support diabetes management.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.